FreeTender
Accepting bidsrfqRussia

Поставка лекарственного препарата МНН ВЕДОЛИЗУМАБ

Supply of the medicinal product MNN VedolizumabEnglish, machine translated

Issued by ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР ИМЕНИ В.А. АЛМАЗОВА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ · via Russia — Сбербанк-АСТ procurement (via B2B-Center/OTC aggregator)

Verify & apply on the official portal →
Published
6 Nov 2026
Closes
13 Nov 2026, 06:00 UTC
Value
RUB 1,636,800
Reference
0372100049626002792
Location
Санкт-Петербург, Russia
Sector
Healthcare & Pharma
Type
goods

At a glance

ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР ИМЕНИ В.А. АЛМАЗОВА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ in Russia has published a request for quotations in healthcare & pharma: “Поставка лекарственного препарата МНН ВЕДОЛИЗУМАБ”. Submissions close on 13 November 2026, 6 days from today. The stated value is RUB 1,636,800. Quote reference 0372100049626002792 in any correspondence with the buyer. FreeTender has recorded 594 notices from this buyer since 2026, 262 of them currently open. There are 21,426 open healthcare & pharma notices in Russia on FreeTender. Bids are submitted to the buyer through Russia — Сбербанк-АСТ procurement (via B2B-Center/OTC aggregator), not through FreeTender.

English summary

Machine translated from Russian by FreeTender. The original notice below is the binding text.

Subject matter of procurement: 1. vedolizumab lyophilisate for the preparation of a concentrate for the preparation of a solution for intravenous administration of 300 mg (OKPD2 21.20.10.214 - Immunosuppressants), 4 800 mg Law: 44-FZ. Purchase method: Request for quotations. Site: JSC "Sberbank-AST". Initial (maximum) price: 1 636 800.00 . Organizer: Federal State Budgetary Institution "National Medical Research Center named after V.A. Almazova" of the Ministry of Health of the Russian Federation. Region: St. Petersburg. Acceptance of applications until: 13.11.2026 09:00 (MSK).

Details

Поставка лекарственного препарата МНН ВЕДОЛИЗУМАБ

Объект закупки:

1. ведолизумаб лиофилизат для приготовления концентрата для приготовления раствора для внутривенного введения 300 мг (ОКПД2 21.20.10.214 – Иммунодепрессанты), 4 800 мг Закон: 44-ФЗ. Способ закупки: Запрос котировок. Площадка: АО «Сбербанк-АСТ». Начальная (максимальная) цена: 1 636 800.00 ₽. Организатор: ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР ИМЕНИ В.А. АЛМАЗОВА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ. Регион: Санкт-Петербург. Приём заявок до: 13.11.2026 09:00 (МСК).

Извещение в ЕИС: https://zakupki.gov.ru/epz/order/notice/view/common-info.html?regNumber=0372100049626002792

Context for bidders

We hold 594 notices from ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "НАЦИОНАЛЬНЫЙ МЕДИЦИНСКИЙ ИССЛЕДОВАТЕЛЬСКИЙ ЦЕНТР ИМЕНИ В.А. АЛМАЗОВА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ, going back to September 2026 — 262 of them still open. They buy mostly in Healthcare & Pharma, Manufacturing & Supply and IT & Telecom. There are 21,426 open Healthcare & Pharma tenders in Russia. This one closes in 6 days.

Similar Healthcare & Pharma tenders

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.
Common bidding mistakes to avoid →Writing a winning proposal

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →